영국의 디지털 헬스케어 시장 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the united kingdom digital healthcare market size is projected to expand from USD 42.93 billion in 2025 and USD 46.36 billion in 2026 to USD 70.54 billion by 2031, registering a CAGR of 8.76% between 2026 to 2031.

This report is Segmented by Offering (Software, Services, Hardware), Technology (Telehealth, Remote Patient Monitoring, Mhealth, Healthcare Analytics and AI, and More), Deployment Mode (Cloud-Based, Hybrid, On-Premise), Application (Chronic Disease Management, and More), End User (Hospitals, and More), and Geography (United Kingdom). Market Forecasts are in Value (USD).

United Kingdom Digital Healthcare Market Trends and Insights

NHS Electronic Patient Record Rollouts Reach Critical Mass

As of the 2025 Digital Maturity Assessment, 93% of NHS providers had a live EPR, yet only 30% had integrated bi-directional data flows, which means the current wave centers on optimization rather than first-time installation. NHS England expects 97% of acute trusts to have EPR coverage by the end of 2026, so rollout work is still feeding demand across the UK digital healthcare market. Local NHS IT spending is projected to rise from GBP 4.9 billion, or USD 6.2 billion, in 2025/26 to GBP 6.8 billion, or USD 8.6 billion, by 2028/29, which gives platform vendors and service partners a longer runway for implementation and support work. The important commercial change is that revenue funding is now being used for EPR optimization, training, and workflow redesign through the NHS Frontline Productivity Programme, which widens spend beyond initial software licensing. This change keeps managed services, integration support, user training, and post-go-live consulting active even in trusts that have already completed major deployments, and it supports recurring rather than one-off contract value.

Virtual Ward Expansion Beyond Acute Settings

NHS England operated 12,825 virtual ward beds in March 2025, and the South East alone recorded more than 85,000 virtual ward admissions in 2024, which was 18% above the 2023 level. The NHS 10 Year Health Plan committed to a national procurement route for a proactive planned care platform, and it linked incentives more directly to community-based urgent care activity. One NHS-commissioned trial found Hospital at Home care to be less expensive than inpatient treatment, with average savings of GBP 2,265, or USD 2,860, per patient episode, and that figure is now shaping local business cases. Pathways for COPD, heart failure, and frailty are now being designed as virtual-first services rather than as add-on pilots, which changes where remote monitoring vendors sit in care delivery. That shift strengthens demand in the UK digital healthcare market for connected devices, workflow platforms, and home-setting data integration that can work within routine NHS operations.

Legacy Interoperability Debt Across NHS Estates

The 2025 Digital Maturity Assessment showed that only 30% of EPR-equipped NHS providers had integrated bi-directional data flows, and this remains one of the clearest limits on connected care growth. NHS England's Frontline Productivity Programme and the NHS Canonical Data Model are intended to narrow this gap, yet the board has stated that full benefits from the Single Patient Record program are not expected to be realized until 2030. Regions that still rely on incompatible systems face slower care pathway redesign, slower data exchange, and more expensive integration work, particularly where acute, community, and mental health services need to coordinate. This delay matters for the UK digital healthcare market because revenue tied to remote monitoring, shared care, and decision support depends on reliable data exchange between settings. Vendors that can demonstrate compliance with FHIR UK Core R4 and NHS GP Connect standards, therefore, have a clearer commercial advantage than those that still depend on bespoke links.

Other drivers and restraints analyzed in the detailed report include:

1. NHS App as a National Digital Front Door
2. AI-Enabled Clinical Workflow Automation
3. Cybersecurity and Clinical Safety Compliance Burden

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Software held 59.27% of the UK digital healthcare market share in 2025, supported by EPR licensing, SaaS-based clinical platforms, and the fast commercial expansion of ambient voice and analytics tools. This leadership reflects structural demand rather than short-term momentum because NHS standardization around a limited set of EPR vendors and app ecosystems creates a large renewal base. The software layer also benefits from the fact that cloud-native clinical platforms are now being treated as long-term operating infrastructure rather than stand-alone projects. That makes procurement less episodic and more tied to multiyear transformation plans across trusts and integrated care systems. It also keeps software deeply embedded in the broader UK digital healthcare industry as trusts seek fewer systems with stronger clinical and administrative coverage.

Services is the fastest-growing segment, with the UK digital healthcare market size for services expected to expand at a 9.08% CAGR from 2026 to 2031. NHS organizations are shifting more budget toward managed services, implementation support, optimization work, and AI-as-a-service after major go-lives. EPR usability surveys showed only 34% of NHS staff felt their EPR made them more efficient, which helps explain why trusts are spending more on training, workflow redesign, and post-implementation support. Hardware remains smaller, but it still matters because virtual ward kits, connected wearables, and remote monitoring devices are central to home-based care models. The planned GBP 2 billion, or USD 2.5 billion, Clinical Digital Health Systems 2.0 framework also shows that NHS contracting is moving toward bundled software and service delivery rather than stand-alone product purchasing.

Telehealth and telemedicine held 35.79% of revenue in 2025, which kept them as the largest technology category in the UK digital healthcare market. Their lead still reflects the long aftereffects of pandemic-era adoption, especially in urgent access, follow-up visits, and pathway redesign for chronic care. Remote patient monitoring is also expanding under this technology base because virtual ward models continue to rely on connected devices, alert systems, and clinician dashboards. mHealth applications are benefiting from the wider function set of the NHS App, which increasingly supports forms, messaging, appointment management, and chronic care interactions. Digital health systems are consolidating around fewer platform providers, which keeps the technology stack more integrated across the UK digital healthcare industry.

Healthcare analytics and AI are the fastest-growing technology segments at an 8.98% CAGR through 2031, driven by predictive operations, decision support, and ambient voice documentation. The NHS Federated Data Platform and related AI safety programs are helping turn data infrastructure into a direct enabler of clinical and operational applications. OECD analysis identified the UK as a leading example of scalable cloud adoption in health and pointed to AI diagnostics procurement as a benchmark for public sector deployment. Digital therapeutics are also growing, but they remain more constrained because NICE evidence pathways still require long validation cycles before broad commissioning support builds. This leaves AI and analytics as the main incremental spending category because they can improve documentation, throughput, triage, and capacity management without always waiting for entirely new care pathways.

Complete Report Scope:

• By Offering
  • Software
  • Services
  • Hardware
• By Technology
  • Telehealth and Telemedicine
  • Remote Patient Monitoring
  • mHealth Applications
  • Healthcare Analytics and AI
  • Digital Health Systems
  • Digital Therapeutics
• By Deployment Mode
  • Cloud-Based
  • Hybrid
  • On-Premise
• By Application
  • Chronic Disease Management
  • Diagnostics and Decision Support
  • Mental Health
  • Preventive and Wellness Care
  • Administration and Workflow Automation
• By End User
  • Hospitals and NHS Trusts
  • Primary Care and GP Practices
  • Patients and Home-Care Settings
  • Payers and Commissioners
  • Pharmaceutical and Life Sciences Companies

List of Companies Covered in this Report:

1. Accurx
2. athenahealth
3. Babylon Health
4. Cera
5. Current Health
6. Dedalus S.p.A.
7. Doccla
8. DrDoctor
9. EMIS Health
10. Epic Systems
11. Fielmann
12. Graphnet Health
13. Huma
14. Intersystems
15. KIND GmbH & Co. KG
16. Livi
17. Oracle Health
18. Patients Know Best
19. Koninklijke Philips
20. System C Healthcare
21. TPP
22. Visionable
23. Veradigm

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 NHS Electronic Patient Record Rollouts
  • 4.2.2 Virtual Ward Expansion Beyond Acute Settings
  • 4.2.3 NHS App as a National Digital Front Door
  • 4.2.4 AI-Enabled Clinical Workflow Automation
  • 4.2.5 Community Care Digitization and Home Monitoring
  • 4.2.6 FHIR-Based Interoperability Standardization
• 4.3 Market Restraints
  • 4.3.1 Legacy Interoperability Debt Across NHS Estates
  • 4.3.2 Cybersecurity and Clinical Safety Compliance Burden
  • 4.3.3 Long Validation Cycles for Regulated Software and AI Tools
  • 4.3.4 Shortage of Clinical Informatics and Health Data Talent
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Industry Rivalry

5 Market Size & Growth Forecasts

• 5.1 By Offering
  • 5.1.1 Software
  • 5.1.2 Services
  • 5.1.3 Hardware
• 5.2 By Technology
  • 5.2.1 Telehealth and Telemedicine
  • 5.2.2 Remote Patient Monitoring
  • 5.2.3 mHealth Applications
  • 5.2.4 Healthcare Analytics and AI
  • 5.2.5 Digital Health Systems
  • 5.2.6 Digital Therapeutics
• 5.3 By Deployment Mode
  • 5.3.1 Cloud-Based
  • 5.3.2 Hybrid
  • 5.3.3 On-Premise
• 5.4 By Application
  • 5.4.1 Chronic Disease Management
  • 5.4.2 Diagnostics and Decision Support
  • 5.4.3 Mental Health
  • 5.4.4 Preventive and Wellness Care
  • 5.4.5 Administration and Workflow Automation
• 5.5 By End User
  • 5.5.1 Hospitals and NHS Trusts
  • 5.5.2 Primary Care and GP Practices
  • 5.5.3 Patients and Home-Care Settings
  • 5.5.4 Payers and Commissioners
  • 5.5.5 Pharmaceutical and Life Sciences Companies

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global Level Overview, Market-level Overview, Core Segments, Financials, Strategic Information, Market Rank/Share, Products & Services, Recent Developments)
  • 6.3.1 Accurx
  • 6.3.2 athenahealth
  • 6.3.3 Babylon Health
  • 6.3.4 Cera
  • 6.3.5 Current Health
  • 6.3.6 Dedalus S.p.A.
  • 6.3.7 Doccla
  • 6.3.8 DrDoctor
  • 6.3.9 EMIS Health
  • 6.3.10 Epic Systems Corporation
  • 6.3.11 Fielmann
  • 6.3.12 Graphnet Health
  • 6.3.13 Huma
  • 6.3.14 InterSystems Corporation
  • 6.3.15 KIND GmbH & Co. KG
  • 6.3.16 Livi
  • 6.3.17 Oracle Health
  • 6.3.18 Patients Know Best
  • 6.3.19 Philips
  • 6.3.20 System C Healthcare
  • 6.3.21 TPP
  • 6.3.22 Visionable
  • 6.3.23 Veradigm

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment